Richard Pulik
Direttore Finanziario/CFO presso ROIVANT SCIENCES LTD.
Patrimonio netto: 3 M $ in data 30/04/2024
Provenienza dei contatti di primo grado di Richard Pulik
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
University of Pennsylvania
822
| College/University | Other Consumer Services | 822 |
| Public Company | Pharmaceuticals: Major | 27 | |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY.
26
| Subsidiary | Pharmaceuticals: Major | 26 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Richard Pulik tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| SIO GENE THERAPIES INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chairman Chief Executive Officer Director/Board Member Director/Board Member | |
| MYOVANT SCIENCES LTD. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Chairman Director/Board Member Director/Board Member Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Graduate Degree Doctorate Degree Masters Business Admin Masters Business Admin Doctorate Degree | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin Undergraduate Degree Masters Business Admin Masters Business Admin | |
| UROVANT SCIENCES LTD. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman Director/Board Member Director/Board Member | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Director/Board Member Chairman Chairman Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Graduate Degree | |
| IMMUNOVANT, INC. | Biotechnology | Director/Board Member Director/Board Member Chairman Director/Board Member | |
Roivant Sciences GmbH
 Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | President Chief Executive Officer Chief Operating Officer | |
Axovant Sciences, Inc.
 Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer | |
Urovant Sciences, Inc.
 Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
| Yale University | College/University | Undergraduate Degree Graduate Degree Masters Business Admin | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Undergraduate Degree Graduate Degree | |
QVT Financial LP
 QVT Financial LP Investment ManagersFinance QVT Financial LP is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded in 2003 by Daniel Gold. QVT Financial provides administrative and/or investment management services to private funds including US limited partnerships, non-US limited partnerships and non-US Corporation. | Investment Managers | Portfolio Manager-Equities Chief Executive Officer Analyst-Equity | |
Kriya Therapeutics, Inc.
 Kriya Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Kriya Therapeutics, Inc. designs and develops transformative new treatments for prevalent and severe chronic diseases. The company was founded by Shankar Ramaswamy and Roger Jeffs and is headquartered in Redwood City, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Immunovant Sciences Ltd.
 Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million. | Biotechnology | Director/Board Member Director/Board Member Chairman | |
Dermavant Sciences Ltd.
 Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Dermavant Sciences Ltd. is a clinical-stage biopharmaceutical company which focuses on developing and commercializing therapeutics in medical dermatology. The company is developing a pipeline of therapies in medical dermatology and is currently advancing development programs for five product candidates which targets specific unmet needs in two of the immuno-dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis and acne. The company was founded on September 28, 2015 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman | |
Dermavant Sciences, Inc.
 Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | Biotechnology | Director/Board Member Director/Board Member Chairman | |
Sumitovant Biopharma, Inc.
 Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sumitovant Biopharma, Inc. provides biotechnology services. It offers oncology, gene therapy, rare, pulmonary, urological disease, digital innovation and novel platforms. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Roivant Social Ventures, Inc. | Director/Board Member Director/Board Member Director/Board Member | ||
| MIT Sloan School of Management | College/University | Masters Business Admin Corporate Officer/Principal Masters Business Admin | |
| Kellogg School of Management | College/University | Graduate Degree Masters Business Admin Masters Business Admin | |
UBS Securities LLC
 UBS Securities LLC Investment ManagersFinance UBS Securities LLC is an investment bank and registered broker/dealer headquartered in New York City. The firm was founded in 1998 as UBS Warburg LLC. They are a subsidiary of UBS Americas Holding LLC, ultimately held by UBS Group AG (SWX: UBSG, NYSE: UBS) in Switzerland. UBS Securities is a primary dealer in US Government securities and provides a full range of investment banking services which includes corporate finance, mergers and acquisitions, capital markets, trading and sales, fixed-income, equity research, private banking, underwriting and prime brokerage operations. The firm also provides advisory services and access to capital markets for corporate, institutional, intermediary and alternative asset management clients. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Doctorate Degree | |
| CAREDX, INC | Medical Specialties | Director/Board Member Director of Finance/CFO | |
| Yale Law School | College/University | Graduate Degree Graduate Degree | |
Orrick, Herrington & Sutcliffe LLP
 Orrick, Herrington & Sutcliffe LLP Miscellaneous Commercial ServicesCommercial Services Orrick, Herrington & Sutcliffe LLP engages in the provision of legal services. Its practices include: antitrust and competition; banking and finance; capital markets; copyright, trademark and false advertising; cyber, privacy and data innovation; employment law and litigation; energy; financial services litigation; global compliance and regulatory, infrastructure; intellectual property; patents; public finance; real estate; securities litigation; supreme court and appellate; tax advocacy; technology transactions; trials; and white collar, investigations, securities litigation and compliance. The company was founded by John R. Garboe in 1863 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal General Counsel | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree | |
Arbutus Biopharma, Inc.
 Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA. | Biotechnology | Director/Board Member Director/Board Member | |
Fidelity Management & Research Co. LLC
 Fidelity Management & Research Co. LLC Investment ManagersFinance Fidelity Management & Research Co. (FMR) is a SEC-registered investment advisor headquartered in Boston, Massachusetts. The firm was founded in 1946 and is a subsidiary of FMR LLC, also known as Fidelity Investments. FMR provides investment supervisory services, which include sub-advisory services, to Fidelity's family of mutual funds and exchange-traded funds, qualified tuition programs, privately offered unregistered investment funds, separately managed account clients, and various other institutional accounts. | Investment Managers | Director of Research - Equity Portfolio Manager-Equities | |
| TOBIRA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Xoc Pharmaceuticals, Inc.
 Xoc Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Xoc Pharmaceuticals, Inc. operates as Biopharmaceutical Company. It focuses on the development of innovative therapeutics. The company was founded by Scott W. Borland, Miguel Guzman and Lisa Borland and is headquartered in Los Gatos, CA. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| The Trustees of Columbia University in The City of New York | College/University | Corporate Officer/Principal Undergraduate Degree | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Tokyo | College/University | Undergraduate Degree Undergraduate Degree | |
Sio Capital Management LLC
 Sio Capital Management LLC Investment ManagersFinance Sio Capital Management LLC (Sio Capital) is an independent registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Dr. Michael Castor in 2006. Sio Capital provides discretionary investment advisory services to domestic and foreign private investment vehicles that are exempt from registration under the Investment Company Act of 1940 and separately managed accounts for institutions and large businesses. | Investment Managers | Analyst-Equity Analyst-Equity | |
Vion Pharmaceuticals, Inc.
 Vion Pharmaceuticals, Inc. BiotechnologyHealth Technology Vion Pharmaceuticals, Inc. develops therapeutics for the treatment of cancer. The company was founded in March 1992 and is headquartered in New Haven, CT. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| AVALO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Stanford University | College/University | Masters Business Admin Undergraduate Degree | |
| TRAWS PHARMA, INC. | Biotechnology | Corporate Officer/Principal Director/Board Member | |
| London School of Economics & Political Science | College/University | Graduate Degree Trading-Fixed Income |
Statistiche
Distribuzione geografica
| Stati Uniti | 43 |
| Regno Unito | 5 |
| Svizzera | 2 |
| Francia | 2 |
| Bermuda | 2 |
Settori
| Health Technology | 24 |
| Consumer Services | 17 |
| Finance | 8 |
| Commercial Services | 4 |
Posizioni
| Director/Board Member | 323 |
| Corporate Officer/Principal | 157 |
| Independent Dir/Board Member | 92 |
| Undergraduate Degree | 90 |
| Chairman | 56 |
Contatti più connessi
| Insiders | |
|---|---|
| Pierre Legault | 45 |
| George Bickerstaff | 37 |
| Frank Torti | 35 |
| Clarence Machado | 30 |
| Meghan Fitzgerald | 28 |
| Kenneth Ludlum | 24 |
| Berndt A. E. Modig | 23 |
| Wan Li Zhu | 22 |
| Omar Al-Madhi | 21 |
| Atul Pande | 20 |
| Howard Marks | 20 |
| Wendell Pritchett | 19 |
| Kathleen Sebelius | 18 |
| Salvatore Tirabassi | 18 |
| Jim Momtazee | 17 |
- Borsa valori
- Insiders
- Richard Pulik
- Connessioni Società
